networking
Meet Apsynora Therapeutics at Nordic Innovation Fair 2026
14 August 2026
networking
Apsynora Therapeutics will be attending Nordic Innovation Fair 2026 in Copenhagen as an emerging biotech start-up, connecting with potential partners, investors, and industry experts. We look forward to sharing our science, exploring collaboration opportunities, and building partnerships to advance our innovative therapeutic programmes.
Nordic Innovation Fair 2026 open_in_new
About Apsynora Therapeutics
Apsynora Therapeutics is a clinical-stage biopharmaceutical company focused on advancing innovative therapeutic solutions. Our lead programme, HT-101, is being developed to reduce or relieve gastrointestinal side effects associated with GLP-1 receptor agonist therapies. By combining clinical development with a science-driven approach, Apsynora Therapeutics aims to improve treatment tolerability and support patients in benefiting from important therapeutic advances.